Implanet SA Total Liabilities
Implanet SA total liabilities. Based on the latest financial reports, Implanet SA (ALIMP) has total liabilities worth €18.04 Million EUR (≈ $21.09 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Implanet SA (ALIMP) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Implanet SA (2010–2025)
Total liabilities of Implanet SA from 2010 to 2025. This chart illustrates how Implanet SA's total liabilities have evolved over time, based on quarterly financial data. Explore Implanet SA long-term investment intensity to see how much of total assets are deployed in long-term investments.
Implanet SA Competitors by Total Liabilities
The table below lists competitors of Implanet SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yukselen Celik As
IS:YKSLN
|
Turkey | TL971.52 Million |
|
Team Young Advanced Technology Co Ltd
TWO:5345
|
Taiwan | NT$1.89 Million |
|
Comelf SA
RO:CMF
|
Romania | RON91.76 Million |
|
Brookside Energy Ltd
AU:BRK
|
Australia | AU$22.08 Million |
|
Renewables Infrastructure Grp
LSE:TRIG
|
UK | GBX2.50 Million |
|
KNW Co. Ltd
KQ:105330
|
Korea | ₩104.16 Billion |
|
Planet Green Holdings Corp
NYSE MKT:PLAG
|
USA | $12.38 Million |
|
FibroBiologics, Inc. Common Stock
NASDAQ:FBLG
|
USA | $8.62 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Implanet SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Implanet SA assets under control.
Liquidity & Leverage Metrics
Implanet SA Total Liabilities Ratios Explained
Implanet SA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 44.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.98 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Implanet SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Implanet SA (2010–2025)
The table below shows the annual total liabilities of Implanet SA from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €18.04 Million ≈ $21.09 Million |
+27.40% |
| 2024-12-31 | €14.16 Million ≈ $16.56 Million |
+31.01% |
| 2023-12-31 | €10.81 Million ≈ $12.64 Million |
-1.12% |
| 2022-12-31 | €10.93 Million ≈ $12.78 Million |
-21.34% |
| 2021-12-31 | €13.90 Million ≈ $16.25 Million |
+80.99% |
| 2020-12-31 | €7.68 Million ≈ $8.98 Million |
-6.50% |
| 2019-12-31 | €8.21 Million ≈ $9.60 Million |
+27.41% |
| 2018-12-31 | €6.45 Million ≈ $7.54 Million |
+2.74% |
| 2017-12-31 | €6.28 Million ≈ $7.34 Million |
-7.69% |
| 2016-12-31 | €6.80 Million ≈ $7.95 Million |
+3.56% |
| 2015-12-31 | €6.56 Million ≈ $7.67 Million |
-10.57% |
| 2014-12-31 | €7.34 Million ≈ $8.58 Million |
-27.00% |
| 2013-12-31 | €10.06 Million ≈ $11.76 Million |
+41.78% |
| 2012-12-31 | €7.09 Million ≈ $8.29 Million |
-9.73% |
| 2011-12-31 | €7.86 Million ≈ $9.19 Million |
+62.44% |
| 2010-12-31 | €4.84 Million ≈ $5.65 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more